HOTH
HEALTHCAREHoth Therapeutics Inc
$0.74+0.03 (+4.15%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving HOTH Today?
No stock-specific AI insight has been generated for HOTH yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.49$2.12
$0.74
Fundamentals
Market Cap$14M
P/E Ratio—
EPS$-0.90
Dividend Yield—
Dividend / Share—
ROE-1.9%
Profit Margin—
Debt / Equity—
Trading
Volume176K
Avg Volume (10D)—
Shares Outstanding19.1M
HOTH News
20 articles- Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer PatientsYahoo Finance·May 5, 2026
- Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming SemaglutideYahoo Finance·Apr 14, 2026
- Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct OfferingYahoo Finance·Apr 2, 2026
- Hoth Therapeutics Announces $2.0 Million Registered Direct OfferingYahoo Finance·Apr 1, 2026
- Hungary Approves Trial Expansion as HT-001 Meets Primary Endpoint in Interim Analysis with Patients Reaching ARIGA ≤1 by Week SixYahoo Finance·Apr 1, 2026
- Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting TechnologyYahoo Finance·Mar 31, 2026
- Hoth Therapeutics Deploys OpenClaw™ AI Platform to Accelerate Drug DiscoveryYahoo Finance·Mar 26, 2026
- Hoth Therapeutics Reports Positive HT-001 PK, Safety, and Clinical Activity Data in Cancer Patients with EGFR Therapy-Associated Skin Toxicities Showing ~77% Increase in Drug Exposure and Minimal Systemic AbsorptionYahoo Finance·Mar 24, 2026
- Hoth Therapeutics Reports Positive Female Preclinical Data Showing HT-VA Restores Cholesterol Levels and Improves Lipid Metabolism in MASLD ModelYahoo Finance·Mar 10, 2026
- Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology ProgramYahoo Finance·Mar 4, 2026
- HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASESYahoo Finance·Feb 24, 2026
- Hoth Therapeutics Receives U.S. Notice of Allowance for Novel Exon-Skipping Therapy Targeting Allergic DiseasesYahoo Finance·Feb 12, 2026
- Hoth Therapeutics Announces Groundbreaking Positive Results: Hoth's HT-VA GDNF Surpasses Semaglutide in Weight Loss, Glucose Control, and Liver Health in Obesity ModelYahoo Finance·Feb 10, 2026
- Hoth Therapeutics Addresses Market Rumor, Hoth Holds No Crypto Currency AssetsYahoo Finance·Feb 5, 2026
- Hoth Therapeutics Delivers 100% Clinical Response with ~50% Reduction in Disease Severity in Open-Label PK Cohort of EGFR-Treated Cancer PatientsYahoo Finance·Jan 22, 2026
- Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP PositionYahoo Finance·Jan 21, 2026
- Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site ActivationYahoo Finance·Jan 15, 2026
- Sector Update: Health Care Stocks Advance Late AfternoonYahoo Finance·Jan 2, 2026
- Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP PlatformYahoo Finance·Jan 2, 2026
- Hoth Therapeutics Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated HT-KIT, Advancing HT-001 Phase 2, and New GDNF Metabolic ProgramYahoo Finance·Dec 3, 2025
All 20 articles loaded
Price Data
Open$0.70
Previous Close$0.71
Day High$0.72
Day Low$0.69
52 Week High$2.12
52 Week Low$0.49
52-Week Range
$0.49$2.12
$0.74
Fundamentals
Market Cap$14M
P/E Ratio—
EPS$-0.90
Dividend Yield—
Dividend / Share—
ROE-1.9%
Profit Margin—
Debt / Equity—
Trading
Volume176K
Avg Volume (10D)—
Shares Outstanding19.1M
About Hoth Therapeutics Inc
Hoth Therapeutics, Inc., a biopharmaceutical company, is focused on developing therapies for dermatological disorders. The company is headquartered in New York, New York.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—